Cardiovascular risk factors in HIV-infected patients on effective antiretroviral therapy;Índices de riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en tratamiento antirretroviral efectivo

Medicina Clinica

Volumn 130, Issue 20, 2008, Pages 797-

  Estébanez, Carlos Tornero ^a   Martín, Alicia Santamaría ^a   Tomás, Eva Gil ^a   Ferri, Consuelo Lapuebla ^a  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT;

ANTHROPOMETRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; LETTER; MORBIDITY; PREVALENCE; SCORING SYSTEM; ADOLESCENT; ADULT; AGED; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 45249122429     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13121107     Document Type: Letter

References (9)

1. The Data Collection on Adverse events of anti HIV drugs (DAD) Study group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
2. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershaltz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
3. Conroy RM, Pyöräla K, Fitgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE Project. Eur Heart J. 2003;24:1601-10.
4. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.
5. Aranceta J, Pérez Rodrigo C, Foz Sala M, Mantilla T, Serra Majem L, Moreno B, et al. Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA. Med Clin (Barc). 2004;123:686-91.
6. The DAD Study group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-35.
7. Jerico C, Knobel H, Sorli ML, Montero A, Guelar A, Pedro-Botet J. Prevalencia de los factores de riesgo cardiovascular en pacientes con infección por VIH. Rev Clin Esp. 2006;11:556-9.
8. th Conference on Retroviruses and Opportunistic Infections; 2005, febrero 22-25; Boston. Boston: CROI; 2005.
9. Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. Factores de riesgo cardiovascular en la población española. Metaanálisis de estudios transversales. Med Clin (Barc). 2005;124:606-12.